Literature DB >> 9273006

[Results of CT-guided periradicular pain therapy].

D Uhlenbrock1, J Arlinghaus.   

Abstract

PURPOSE: The effectiveness of CT-guided periradicular pain therapy was studied. MATERIAL AND
METHOD: 55 patients with lumbar and/or radicular pain were treated by periradicular injections of 40 ml triamcinolon, in some cases combined with injection of the facets of the lumbar vertebrae. 36 patients had chronic symptoms; in 7, these were acute, and 12 patients complained of renewed disc symptoms following previous disc surgery. Approximately 4 months after the conclusion of treatment, the patients were requested to complete a questionnaire giving information on the course and after-effects of treatment. The questionnaire was repeated after 5 months.
RESULTS: 55% of patients were free of symptoms or had had some improvement at the time of the questionnaire; 30% reported temporary improvement, and in 15% there was no change compared with the pre-treatment symptoms. At the time of the second questionnaire, the proportion of patients who had derived benefit from the treatment was somewhat lower, 49% reported that they were pain-free or improved, while temporary improvement was reported by 36% of patients.
CONCLUSION: CT-guided periradicular pain therapy is a valuable procedure in patients in whom conservative measures prove ineffective, and when surgery is not indicated. However, only about half the treated patients maintain permanent improvement.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9273006     DOI: 10.1055/s-2007-1015471

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  2 in total

1.  Safety of CT-Guided Lumbar Nerve Root Infiltrations. Analysis of a Two-Year Period.

Authors:  Johannes Gossner
Journal:  Interv Neuroradiol       Date:  2014-10-17       Impact factor: 1.610

2.  Cost comparison of nerve root infiltration of the lumbar spine under MRI and CT guidance.

Authors:  M H Maurer; N Schreiter; M de Bucourt; C Grieser; D M Renz; T Hartwig; B Hamm; F Streitparth
Journal:  Eur Radiol       Date:  2013-01-12       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.